ArriVent BioPharma, Inc.

Q3 2026 13F Holders

Symbol
AVBP
CUSIP
04272N102
Type
Equity
Class
COM
Num filings
4
Total reported value, excl. options
$53.9 k
Manager Report Date Value ($000) Shares Option Type